Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease.
about
ANKS3 Co-Localises with ANKS6 in Mouse Renal Cilia and Is Associated with Vasopressin Signaling and Apoptosis In Vivo in MiceEffect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK RatsPatient Survey of current water Intake practices in autosomal dominant Polycystic kidney disease: the SIPs survey.The importance of total kidney volume in evaluating progression of polycystic kidney diseaseDeciphering physiological role of the mechanosensitive TRPV4 channel in the distal nephron.Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study.Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease.Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.Long-term effect of coffee consumption on autosomal dominant polycystic kidneys disease progression: results from the Suisse ADPKD, a Prospective Longitudinal Cohort Study.Secretin, at the hub of water-salt homeostasis.The vasopressin system: new insights for patients with kidney diseases: Epidemiological evidence and therapeutic perspectives.Novel treatments of autosomal dominant polycystic kidney diseaseUrine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial.Validation of Surrogates of Urine Osmolality in Population Studies.Caveat emptor: if you have PKD, be careful of what you drink?A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model.Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations.Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial.Aquaporin Membrane Channels in Oxidative Stress, Cell Signaling, and Aging: Recent Advances and Research Trends.
P2860
Q27321009-454DCC9E-6770-4DD6-902E-E1B09616DD2DQ30412552-8EC91A3B-795B-4FEA-8D00-39087DFD3BE9Q33783023-11205E60-512A-469C-8EE4-8084066BC9ACQ33873107-6436A880-21DE-4BB4-BAF9-7B3BCD5CF88DQ35086473-83899906-1A90-4668-A800-60B15DB3534BQ35658585-EA6A7106-7F19-43F3-BA47-3A62E548B063Q35890367-4AA24C74-8804-479A-BAC1-E1DF6FBE02E3Q38737946-8203A21E-5187-48F8-828D-D55BBBA97972Q38848641-615669F6-1C00-4192-A8E3-77F2E46050A6Q38859778-9011776C-BDB9-4D17-97F0-DB7765EDDC37Q41998074-C8F9A909-5E55-45E5-BE7C-4214B03A97FDQ42556481-6EB09C36-1100-4DC8-94EF-1D9A17A6C7F7Q47925751-E1FB39E8-8473-44D5-A139-9147725CD562Q48015191-EA68B412-D124-4C66-9FE6-F118B8BB6507Q48209915-0AD756F0-D076-4A92-A618-B1BB5B6A5630Q49198447-02EA0AAB-342F-4E4D-9E09-82EF4D0D2B8FQ50048323-FC0A1A62-2D49-40A3-86E9-CEA84927374BQ53823696-36F24631-2697-4F42-B2B3-A8BC1ADA6B87Q55236425-2482EEB0-EC1C-43CC-9FBF-40B077F62D40
P2860
Osmoregulation, vasopressin, and cAMP signaling in autosomal dominant polycystic kidney disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Osmoregulation, vasopressin, a ...... ant polycystic kidney disease.
@en
type
label
Osmoregulation, vasopressin, a ...... ant polycystic kidney disease.
@en
prefLabel
Osmoregulation, vasopressin, a ...... ant polycystic kidney disease.
@en
P1476
Osmoregulation, vasopressin, a ...... ant polycystic kidney disease.
@en
P2093
Vicente E Torres
P304
P356
10.1097/MNH.0B013E3283621510
P577
2013-07-01T00:00:00Z